C. Lugnier

发表

Attitude towards and perception of individual safety after SARS-CoV-2 vaccination among German cancer patients

S. Pfaender, A. Reinacher-Schick, U. Kiltz, 2022, Journal of Cancer Research and Clinical Oncology.

Histopathologic Regression and Survival in RAS Wildtype Metastatic Colorectal Cancer Under First-Line Treatment – Subgroup Analysis of the VOLFI Trial (AIO-KRK-0109)

V. Heinemann, T. Seufferlein, U. Martens, 2021, International Journal of Clinical Oncology and Cancer Research.

Hamartin Variants That Are Frequent in Focal Dysplasias and Cortical Tubers Have Reduced Tuberin Binding and Aberrant Subcellular Distribution In Vitro

A. Becker, S. Schoch, M. Nellist, 2009, Journal of neuropathology and experimental neurology.

A Framework for Falsifiable Explanations of Machine Learning Models with an Application in Computational Pathology

A. Mosig, K. Gerwert, A. Tannapfel, 2021, medRxiv.

The CIRCULATE Trial: Circulating Tumor DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II Evaluation (AIO-KRK-0217).

D. Aust, J. Weitz, G. Folprecht, 2021, Clinical colorectal cancer.

Causes of mortality in elderly UICC stage III colon cancer (CC) patients––Tumor‐related death and competing risks from the German AIO colorectal study group Colopredict Plus (CPP) registry

S. Hollerbach, A. Tannapfel, A. Reinacher-Schick, 2022, Cancer medicine.

Fast and label-free automated detection of microsatellite status in early colon cancer using artificial intelligence integrated infrared imaging.

A. Mosig, K. Gerwert, A. Tannapfel, 2023, European journal of cancer.

A F RAMEWORK FOR F ALSIFIABLE E XPLANATIONS OF M ACHINE L EARNING M ODELS WITH AN A PPLICATION IN C OMPUTATIONAL P ATHOLOGY

A. Mosig, K. Gerwert, A. Tannapfel, 2021 .

Longitudinal data on humoral response and neutralizing antibodies against SARS-CoV-2 Omicron BA.1 and subvariants BA.4/5 and BQ.1.1 after COVID-19 vaccination in cancer patients

S. Pfaender, E. Steinmann, A. Reinacher-Schick, 2023, Journal of Cancer Research and Clinical Oncology.

Mental burden and moral distress among oncologists and oncology nurses in Germany during the third wave of the COVID-19 pandemic: a cross-sectional survey

P. Michl, A. Reinacher-Schick, J. Schildmann, 2023, Journal of Cancer Research and Clinical Oncology.

A. Reinacher-Schick, A. Tannapfel, S. Kasper, 2023, Forum.

Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor Entities

B. Hadaschik, S. Kuemmel, N. Hirmas, 2022, The Journal of Nuclear Medicine.

68Ga-Labeled Fibroblast Activation Protein Inhibitor (68Ga-FAPI) PET for Pancreatic Adenocarcinoma: Data from the 68Ga-FAPI PET Observational Trial

N. Hirmas, J. Ferdinandus, L. Kessler, 2023, The Journal of Nuclear Medicine.

Prognostic Implications of 68Ga-FAPI-46 PET/CT–Derived Parameters on Overall Survival in Various Types of Solid Tumors

N. Hirmas, H. Grafe, B. von Tresckow, 2024, The Journal of Nuclear Medicine.

Diagnostic Accuracy of 68Ga-FAPI Versus 18F-FDG PET in Patients with Various Malignancies

N. Hirmas, C. Kesch, L. Kessler, 2024, Journal of Nuclear Medicine.

68Ga-FAPI-46 PET for cancer imaging: A prospective single-arm clinical trial.

B. Hadaschik, S. Kuemmel, N. Hirmas, 2023, Journal of Clinical Oncology.

What does “urgency” mean when prioritizing cancer treatment? Results from a qualitative study with German oncologists and other experts during the COVID-19 pandemic

S. Nadolny, Helene Hense, C. Lugnier, 2024, Journal of cancer research and clinical oncology.